A company that produces supplies for biopharmaceutical firms plans to set up a new facility in Tennessee that is expected to create 1,400 jobs.
The state Department of Economic and Community Development says Thermo Fisher Scientific has committed to invest more than $100 million in the new assembly center in the Nashville suburb of Lebanon, Tennessee. The facility will produce bioprocess containers and fluid transfer assemblies for companies that develop therapeutics and vaccines.
The Waltham, Massachusetts-based company has annual revenues exceeding $30 billion and serves the pharmaceutical and biotech industries, hospitals and clinical diagnostic labs, universities, research institutions and government agencies.
The project aims to create 400 jobs in the near term and 1,400 over several years. Thermo Fisher will hire workers for roles in manufacturing, assembling and packaging bioprocess containers with additional roles in engineering, procurement, quality, warehousing and site leadership.
“Thermo Fisher’s Nashville site will play a critical role in the company’s effort to support the global pharmaceutical industry’s work in developing life-saving biologics and vaccines to address many diseases,” said Michel Lagarde, executive vice president, Thermo Fisher Scientific. “We look forward to being part of the community and enabling the local talent to build meaningful careers through the high-quality jobs that will be created at the site.” –